A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

This study has been completed.

Sponsor:

Information provided by:

University College London Hospitals

ClinicalTrials.gov Identifier:

NCT00257855

First received: November 22, 2005

Last updated: February 5, 2010

Last verified: February 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	February 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)

No publications provided by University College London Hospitals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Miller DH. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol. 2010 Jul;9(7):681-8. Epub 2010 Jun 8.

To Top